Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHM | CIB |
|---|---|---|
| Price | $114.72 | $90.16 |
| Change today | ▼ 1.15% | ▼ 2.90% |
| Market cap | $21.50B | $21.29B |
| Return, 3 months | -13.3% | +19.0% |
| Return, year to date | -1.5% | +51.2% |
| Return, 1 year | -13.9% | +84.9% |
| P/E (TTM) | 11.7 | 15.5 |
| P/B | 1.7 | 2.4 |
| P/E percentile vs own 5y | 92nd | 89th |
| Dividend yield | 0.87% | 3.00% |
| Revenue growth (YoY, latest qtr) | -9.6% | +21.9% |
| Net profit growth (YoY) | -22.4% | +52.1% |
| Gross margin | 25.2% | – |
| Operating margin | 15.6% | – |
| Net margin | 11.6% | 8.2% |
| Return on equity | 14.9% | 6.1% |
| Analyst target vs. price | +27.4% | +15.4% |
| Analyst buy share | 64% | 67% |
| RSI (14) | 39 | 45 |
| 30-day volatility | 28.0% | 28.1% |
| Max drawdown, 1 year | -22.6% | -24.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
